Mutations in the NF2 gene can lead to a loss of merlin function, which is associated with the development of Neurofibromatosis Type 2 (NF2). This genetic disorder is characterized by the growth of non-cancerous tumors in the nervous system, particularly schwannomas and meningiomas. Additionally, loss of merlin function can contribute to other forms of tumorigenesis.
